Abstract:Although the association of elevated homocysteine level with cardiac hypertrophy has been reported, the molecular mechanisms by which homocysteine induces cardiac hypertrophy remain inadequately understood. In this study we aim to uncover the roles of cyclic nucleotide phosphodiesterase 1 (PDE1) and endoplasmic reticulum (ER) stress and their relationship to advance the mechanistic understanding of homocysteine-induced cardiac cell hypertrophy. H9c2 cells and primary neonatal rat cardiomyocytes are exposed to homocysteine with or without ER stress inhibitor TUDCA or PDE1-specific inhibitor Lu AF58027, or transfected with siRNAs targeting PDE1 isoforms prior to homocysteine-exposure. Cell surface area is measured and ultrastructure is examined by transmission electron microscopy. Hypertrophic markers, PDE1 isoforms, and ER stress molecules are detected by q-PCR and western blot analysis. Intracellular cGMP and cAMP are measured by ELISA. The results show that homocysteine causes the enlargement of H9c2 cells, increases the expressions of hypertrophic markers β-MHC and ANP, upregulates PDE1A and PDE1C, promotes the expressions of ER stress molecules, and causes ER dilatation and degranulation. TUDCA and Lu AF58027 downregulate β-MHC and ANP, and alleviate cell enlargement. TUDCA decreases PDE1A and PDE1C levels. Silencing of PDE1C inhibits homocysteine-induced hypertrophy, whereas PDE1A knockdown has minor effect. Both cAMP and cGMP are decreased after homocysteine-exposure, while only cAMP is restored by Lu AF58027 and TUDCA. TUDCA and Lu AF58027 also inhibit cell enlargement, downregulate ANP, β-MHC and PDE1C, and enhance cAMP level in homocysteine-exposed primary cardiomyocytes. ER stress mediates homocysteine-induced hypertrophy of cardiac cells via upregulating PDE1C expression Cyclic nucleotide, especially cAMP, is the downstream mediator of the ER stress-PDE1C signaling axis in homocysteine-induced cell hypertrophy.

Endoplasmic reticulum stress induces cardiac dysfunction through architectural modifications and alteration of mitochondrial function in cardiomyocytes

Endoplasmic Reticulum Stress and Heart Diseases

SIRT1 Protects the Heart from ER Stress-Induced Injury by Promoting eEF2K/eEF2-Dependent Autophagy

ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics

Endoplasmic Reticulum Stress Induced by Turbulence of Mitochondrial Fusion and Fission Was Involved in Stressed Cardiomyocyte Injury.

Endoplasmic reticulum stress in the heart: insights into mechanisms and drug targets

Endoplasmic Reticulum Stress and Metabolic Dysfunction

Activation of Akt Rescues Endoplasmic Reticulum Stress-Impaired Murine Cardiac Contractile Function Via Glycogen Synthase Kinase-3Β-mediated Suppression of Mitochondrial Permeation Pore Opening.

ER stress in skeletal muscle remodeling and myopathies

Endoplasmic Reticulum Stress and Diabetic Cardiomyopathy

Endoplasmic Reticulum Stress: a Novel Mechanism and Therapeutic Target for Cardiovascular Diseases

Oxidative Activation of Ca(2+)/calmodulin-activated Kinase II Mediates ER Stress-Induced Cardiac Dysfunction and Apoptosis.

Heavy Metal Scavenger Metallothionein Attenuates ER Stress-Induced Myocardial Contractile Anomalies: Role of Autophagy

Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases

Endoplasmic Reticulum Stress: A Key Regulator of Cardiovascular Disease

Antioxidant Metallothionein Alleviates Endoplasmic Reticulum Stress-Induced Myocardial Apoptosis and Contractile Dysfunction

Endoplasmic Reticulum and the Microrna Environment in the Cardiovascular System

Aerobic exercise training rescues cardiac protein quality control and blunts endoplasmic reticulum stress in heart failure rats

Endoplasmic reticulum stress mediates homocysteine-induced hypertrophy of cardiac cells through activation of cyclic nucleotide phosphodiesterase 1C

Abstract 16337: Endoplasmic Reticulum Stress Contributes to Cardiomyocyte Apoptosis in Trauma-Induced Secondary Cardiac Injury

Endoplasmic reticulum stress and protein quality control in diabetic cardiomyopathy.